Who’s Going to Meeting on the Mesa 2026
Oct 5–7, 2026 Phoenix, AZ ~1.5k attendees Website
592 organizations at Meeting on the Mesa 2026, a ~1,500-person partnering meeting of cell and gene therapy dealmakers, investors and manufacturing partners. As of Sep 29, 2026.
| Organization | Meeting on the Mesa 2026 Attendance |
|---|---|
Catalent Tampa, FL | ◆Diamond Sponsor |
Contract development and manufacturing services for pharmaceuticals, biologics, cell and gene therapies, including viral vectors, clinical supply and commercial production. | Spotlight Mon, Oct 5 10:45am Chair Mon, Oct 5 8:00am Chair Wed, Oct 7 9:00am |
Arbor Biotechnologies Cambridge, MA | ◇Silver Sponsor |
Develops gene-editing therapeutics for genetic diseases, including liver and central nervous system conditions and rare disorders. | Spotlight Mon, Oct 5 10:45am Panel Tue, Oct 6 4:15pm |
Astellas Tokyo, Japan | ◆Diamond Sponsor |
Develops and commercializes medicines, with partnering interests in oncology, rare diseases, immunology, cell therapies and gene therapies. | Spotlight Tue, Oct 6 3:30pm |
Cell and Gene Therapy Catapult London, United Kingdom | ◆Gold Sponsor |
Provides cell and gene therapy research, process development, manufacturing, and regulatory support to accelerate commercialization. | Spotlight Tue, Oct 6 10:45am Panel Mon, Oct 5 4:00pm |
Children’s National Hospital Washington, DC | ◇Silver Sponsor |
Provides pediatric hospital care and develops treatments for genetic and rare diseases through clinical and translational research. | Spotlight Mon, Oct 5 5:15pm Panel Mon, Oct 5 10:45am |
CTI Clinical Trial & Consulting Services Covington, KY | ◆Diamond Sponsor |
Provides clinical research, regulatory consulting, site management, and laboratory services for biopharmaceutical trials, including cell and gene therapies and rare diseases. | Spotlight Mon, Oct 5 3:00pm Chair Mon, Oct 5 1:30pm |
ElevateBio Waltham, MA | ◆Diamond Sponsor |
Provides gene-editing technologies, discovery services, and cGMP development and manufacturing for advanced therapy companies from early research through commercialization. | Spotlight Mon, Oct 5 11:45am Panel Mon, Oct 5 5:00pm |
Kyverna Therapeutics Emeryville, CA | ◇Silver Sponsor |
Develops CAR T-cell therapies for autoimmune diseases, including autologous and allogeneic products with rapid manufacturing processes. | Spotlight Mon, Oct 5 2:30pm Panel Tue, Oct 6 1:30pm |
Precision for Medicine Bethesda, MD | ◆Platinum Sponsor |
Provides biomarker-driven CRO services, clinical trials, specialty laboratories, biospecimens, data science, and companion diagnostic support. | Spotlight Mon, Oct 5 12:00pm Panel Tue, Oct 6 9:00am |
REGENXBIO Rockville, MD | ◇Silver Sponsor |
Develops AAV gene therapies for retinal and rare diseases, including programs for wet AMD, diabetic retinopathy, Duchenne muscular dystrophy, and MPS II. | Spotlight Mon, Oct 5 11:00am |
Rocket Pharmaceuticals, Inc. Cranbury, NJ | ◇Silver Sponsor |
Develops gene therapies for rare cardiovascular diseases, with additional programs in hematology and immunology and proprietary AAV manufacturing capabilities. | Spotlight Mon, Oct 5 11:30am |
Accellix San Jose, CA | ◆Gold Sponsor |
Provides automated flow cytometry instruments and assays for quality control of cell and gene therapy manufacturing. | Spotlight Tue, Oct 6 11:30am |
AGC Biologics Bothell, WA | ◆Platinum Sponsor |
Manufactures therapeutic proteins, plasmid DNA, viral vectors and genetically engineered cells for biopharmaceutical developers, including rare-disease programs. | Spotlight Tue, Oct 6 3:30pm |
Bionova Scientific Fremont, CA | ◆Gold Sponsor |
Provides development and GMP manufacturing of recombinant proteins and plasmid DNA, from cell line development through commercial production. | Spotlight Mon, Oct 5 2:15pm |
Instantly find 20 buyers from companies at Meeting on the Mesa 2026
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
What conference is this?
The Cell & Gene Meeting on the Mesa is the Alliance for Regenerative Medicine’s annual partnering meeting for the cell, gene and regenerative medicine industry, held October 5–7, 2026 at the Arizona Biltmore in Phoenix. It is a dealmaking meeting rather than a scientific congress: company presentations, one-to-one partnering and a program on manufacturing, financing, regulation and reimbursement.
What is in this guide?
Every organization we can place at Meeting on the Mesa 2026: all 592 of them, from the meeting’s own published attendee list, its 139 sponsors, and the 52 Innovation Spotlight presentations and program sessions — each with a short description of what the organization does — plus the 185 people who said in a public post that they will be there. People appear as job titles, never by name.
Where do the named attendees come from?
From their own public posts. 185 people said on LinkedIn or Bluesky that they will be at the meeting, or were named in their company’s post about it, across 112 posts published before Sep 29 2026. Each shows as a short quote from the post, with every person’s name removed, linked to the post itself. Posts that only promote a company, or that never say who will attend, are left out, and so is anyone already on the program.
How are organizations typed?
By what they bring to a partnering meeting: therapy developers (cell and gene therapy companies, pharma and large biotech), the capital chasing them (venture, private equity and banks), the suppliers and services around them (CDMOs and CROs, tools and equipment, regulatory, logistics and consulting), and academic, hospital, nonprofit, government and media organizations. Focus areas come from the organization’s own profile where it publishes one, or from public sources otherwise.
Is the attendee list official?
Yes — the meeting publishes it. 329 of the organizations here appear on that list without also sponsoring or presenting, and their rows say so. The list names organizations only, never individual attendees.
How current is it?
Pulled from the public attendee list, sponsor directory, Innovation Spotlight listings and agenda, and from LinkedIn and Bluesky posts, on Sep 29 2026.
Browse Meeting on the Mesa 2026 by
Organizations with their own page
295 organizations — every exhibitor and every organization with 1 or more presentations.
- AABB
- ABEC
- Accellix
- AGC Biologics
- Agilent Technologies
- AIT Worldwide Logistics
- Akron Bio
- Aldevron
- Alliance for Regenerative Medicine
- American Pharmaceutical Review
- American Red Cross
- Andelyn Biosciences
- Antion Biosciences
- Applied StemCell
- Arbor Biotechnologies
- Arizona State University
- ARMI | BioFabUSA
- Arovella Therapeutics
- ARPA-H
- Artis BioSolutions
- Artiva Biotherapeutics
- Ascend Advanced Therapies
- Ascidian Therapeutics
- ASEBIO
- Aseptic Technologies
- Asimov
- Aspect Biosystems
- Aspen Neuroscience
- Astellas
- AstraZeneca
- Aurion Biotech
- Autolus
- Avectas
- AviadoBio
- Avista Therapeutics
- Beam Therapeutics
- BioCurie
- BioLamina
- Bionova Scientific
- BioPartner UK
- BioPharma Asia
- BioProcess Online
- BioSpherix
- Black Mesa
- BlueRock Therapeutics
- BlueWhale Bio
- BOOST PHARMA
- Boreal Biomanufacturing
- Boston Biodevelopment
- Boston BioProducts
- BridgeBio
- Bristol Myers Squibb
- C3i
- Cabaletta Bio
- California Institute for Regenerative Medicine
- Cardinal Health
- Caring Cross
- Catalent
- CATUG Biotechnology
- Celaid Therapeutics
- Cell & Gene
- Cell & Gene Therapy Review
- Cell and Gene Therapy Catapult
- Cellares
- Cellbox Solutions
- CellBri
- Celleo
- Cellistic
- Cellular Origins
- Cencora World Courier
- CGT Global
- Charles River
- Children’s National Hospital
- Circio
- City of Hope
- City of Phoenix
- Clarion Cells
- Clinigen
- CoJourney
- CompareNetworks
- Complement Therapeutics
- Comprehensive Cell Solutions
- Convey Bio
- Coralis Bio
- CPTx
- CREATE Medicines
- Creighton University
- Cryoport Systems
- CTI Clinical Trial & Consulting Services
- Custom Biogenic Systems
- Cytiva
- Danaher
- Dark Horse Consulting Group
- Delin Ventures
- Discovery Life Sciences
- Discovery Oasis
- Discovery Square
- EBD Group
- Editas Medicine
- Element Materials Technology
- ElevateBio
- Eli Lilly
- Emily Whitehead Foundation
- Emmecell
- Ernexa Therapeutics
- Evia Bio
- Evotec
- eXmoor Pharma
- Exonic
- ExpressionEdits
- Exthymic
- Fairway Consulting Group
- Forge Biologics
- Form Bio
- Forum for Innovative Regenerative Medicine (FIRM)
- Foundation for Angelman Syndrome Therapeutics
- Franklin Biolabs
- Fred Hutchinson Cancer Center
- Frederick County Office of Economic Development
- FreeMind Group
- FUJIFILM Cellular Dynamics
- GEMMABio
- Gene Therapy Canada
- GeneFab
- GENETHON
- Genetix Biotherapeutics
- Genezen
- Genoplex
- Germfree
- Gilead Sciences
- Glidepath Health
- Global Pharma Solutions
- Gordon MD Global Investments
- Granza Bio
- Greater Phoenix Economic Council
- Harro Höfliger
- Haystack Project
- iCell gene Therapeutics
- IDT Biologika
- Immusoft
- InspiroGene by McKesson
- Intellia Therapeutics
- InterAct Therapeutics
- Invetech
- Iovance
- Jennison
- Kenai Therapeutics
- Kincellis
- Kite Pharma
- Kolon TissueGene
- Kytopen
- Kyverna Therapeutics
- Labcorp
- Lachman Consultants
- Latus Bio
- Laverock Therapeutics
- Legend
- leon-nanodrugs
- Life Sciences Review
- Lonza
- Lumanity
- LyGenesis
- Made Scientific
- Mahzi Therapeutics
- March Biosciences
- Marken
- MaxCyte
- Mayo Clinic
- Medicines and Healthcare products Regulatory Agency
- MEDIPOST
- Metagenomi Therapeutics
- Metcela
- MilliporeSigma
- Miltenyi Biotec
- Minaris Advanced Therapies
- Ministry of Economy, Trade and Industry
- Mirai Bio
- Miromatrix
- MKC Biotherapeutics
- Morphocell Technologies
- MPC Therapeutics
- myTomorrows
- Nanoscope Therapeutics
- National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)
- Nionyx Bio
- Nova Biomedical
- Novartis
- Novel Bio
- Novo Holdings
- NTrans Technologies
- NysnoBio
- Ocugen
- OmniaBio
- Optieum Biotechnologies
- Optima Pharma
- Opus Regulatory
- OrbiMed
- Orca Bio
- Organoids by Southwest (OXSW)
- Ori Biotech
- Orphan Therapeutics Accelerator
- Oxford Biomedica Solutions
- PackGene Biotech
- ParcelBio
- Parexel
- PBS Biotech
- Peli BioThermal
- Perpetuu Biosciences
- Pharmaceuticals and Medical Devices Agency
- Pierre Fabre Pharmaceuticals
- Pluristyx
- PolTREG
- Porton Advanced Solutions
- PQP Group
- Precision BioSciences
- Precision Environments
- Precision for Medicine
- Premier Research
- Prime Medicine
- ProBio
- Project Farma
- Quintessence Biotech
- RARE Foundation
- RareKids-CAN
- Rarity PBC
- Ray Therapeutics
- REGENXBIO
- Resolution Therapeutics
- Restem Group
- Revolution Biomanufacturing
- RheumaGen
- Richter BioLogics
- Roche CustomBiotech
- Rocket Pharmaceuticals, Inc.
- RoosterBio
- Rose BioSolutions
- RoslinCT
- RTW Funds
- RTW Institute
- Samsara Biocapital
- SanBio
- Sano Genetics
- Sarepta
- Sartorius
- Satellite Biosciences
- ScaleReady
- Scribe Therapeutics
- Secretome Therapeutics
- SereNeuro Therapeutics
- SGS
- SK pharmteco
- Skylark Bio
- SmartCella
- SMAT Consultants
- Solid Biosciences
- Sonoma Biotherapeutics
- Specific Biologics
- Spur Therapeutics
- StimulusBio
- Stryde Research
- Sumitomo Corporation
- Sumitomo Pharma America
- Syenex
- Syneos Health
- Syner-G
- Tacit Therapeutics
- Teknova
- Tema Sinergie
- Tenaya Therapeutics
- Terumo Blood and Cell Technologies
- Tessera Therapeutics
- The George Washington University
- The Medicine Maker
- Thermo Fisher Scientific
- Touchlight
- TreeFrog Therapeutics
- Trogenix Limited
- U.S. Food and Drug Administration
- Ultragenyx
- uniQure
- United Therapeutics Corporation
- University of Arizona
- University of California, San Francisco
- University of Pennsylvania
- VERIGRAFT
- Viralgen
- Virica Biotech
- ViroSpark BioConsulting
- Vitalant
- VIVEbiotech
- Vor Bio
- Wacker Biotech
- WhiteLab Genomics
- Worldwide Clinical Trials
- Xiogenix
Not affiliated with or endorsed by the Alliance for Regenerative Medicine or the Cell & Gene Meeting on the Mesa. Submit a correction